Print
Email
Print Edition StoriesWednesday, November 11, 2009
Metabolix makes $27M public offering
By Mass High Tech staff
MHT's Galen Moore: Honoring innovation in New England
Funding drugs for rare diseases
MHT's Julie Donnelly: Life science startups finding investments
Cambridge bioscience company Metabolix Inc. has announced a public offering that could bring in about $27 million for the company. Expected to close Nov. 16, 2009, the offering of three million shares of company stock is priced at $9 per share.
Proceeds from the offering will be used for “working capital and other general corporate purposes,” company officials said.
As part of the offering, the underwriters, Jefferies & Co. and Thomas Weisel Partners LLC, have a 30-day option to buy up to 450,000 shares for potential over-allotments, giving Metabolix the potential to receive up to $31 million, before associated expenses.
Founded in 1992, Metabolix (Nasdaq: MBLX) develops a series of bioplastics and biodegradable alternatives to petroleum-based plastics, in addition to the technology to make plastics, energy and chemicals from raw materials.
Last month, Metabolix was awarded a $350,000 grant for research into how to make biobased and biodegradable resins suitable for the plastic beverage bottles and other containers.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.